STAT

JUNE 20, 2024

Gestational diabetes affects one in seven expecting women globally and rates of this troubling condition are rising.   Gestational diabetes has long been diagnosed between weeks 24 and 28 of pregnancy.

Diabetes 332

Diabetes 332

STAT

SEPTEMBER 21, 2023

An advisory panel to the Food and Drug Administration unanimously voted against a diabetes implant from Intarcia Therapeutics — a former biotech unicorn that faltered after the FDA rejected said implant not once, but twice.

Diabetes 353

Diabetes 353

STAT

JUNE 21, 2024

ORLANDO — Twelve people with type 1 diabetes who received a therapy derived from stem cells were able to produce enough of their own insulin to maintain healthy blood glucose levels 90 days later, Vertex Pharmaceuticals said Friday.

Diabetes 362

Diabetes 362

STAT

JANUARY 3, 2025

Diagnosed about 20 years ago with type 2 diabetes, he was delighted to see his blood sugar levels improve dramatically about a year ago, when he started taking Ozempic. 

Diabetes 312

Diabetes Drug Pricing 312

STAT

JUNE 25, 2023

SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an increasingly prevalent condition that can lead to serious liver damage.

Diabetes 351

Diabetes 351

STAT

OCTOBER 30, 2024

Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage list for over two years, with different doses being listed in shortage at various times.

Compounding Pharmacies 336

Compounding Pharmacies Compounding Diabetes 336

STAT

JUNE 23, 2023

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease. 

Diabetes 364

Diabetes 364

PharmaVoice

NOVEMBER 5, 2024

Sernova’s technology helped type 1 diabetes patients achieve insulin independence in early- and mid-stage trials.

Diabetes 312

Diabetes 312

STAT

NOVEMBER 15, 2023

LONDON — Clinical trials have shown that lifestyle programs — which include diet, exercise, and behavioral coaching — can help people in danger of developing type 2 diabetes from tipping into a diagnosis of the condition. A study published Wednesday backs up the idea that they can. Read the rest…

Diabetes 310

Diabetes 310

STAT

JUNE 21, 2024

ORLANDO — The United States is at a critical juncture in its efforts to treat chronic diseases, particularly type 2 diabetes, and now has a chance to change the dangerous trajectory it’s currently following, FDA Commissioner Robert Califf said Friday. “The U.S.

Diabetes 338

Diabetes 338

STAT

NOVEMBER 26, 2024

  Amgen said Tuesday that that its drug, MariTide , led to an average of roughly 20% weight loss over a year in the Phase 2 study in participants who had obesity or who were overweight without type 2 diabetes. The company added that weight loss had not plateaued at that point, suggesting that there was potential for more weight loss.

Diabetes 325

Diabetes Drug Development 325

NY Times

JUNE 20, 2025

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.

Diabetes 111

Diabetes 111

STAT

MARCH 21, 2024

The last decade has seen billions of dollars flow into digital health companies that promise to improve outcomes for the 38 million Americans living with type 2 diabetes. As a result, they don’t reduce health care spending — they drive it up.

Diabetes 352

Diabetes 352

STAT

MAY 8, 2024

In type 1 diabetes, immune fighters attack beta cells in the pancreas that produce insulin, the hormone that controls glucose levels in the blood. Tolerance is the holy grail in calming autoimmune disease, a truce in the immune system’s faulty battle against the body’s own fabric. Read the rest…

Diabetes 319

Diabetes Immunity Immunization 319

STAT

JUNE 23, 2025

Obesity drugs were first approved to treat type 2 diabetes, but there’s a growing movement to test them in type 1 diabetes, too. Research presented Monday at a large diabetes meeting showed some promise for this approach.

Diabetes 245

Diabetes 245

STAT

JANUARY 7, 2025

The advent of the first generic GLP-1 drugs could help Medicare negotiate a lower price for the highly sought after diabetes and obesity medication semaglutide , according to experts familiar with the price-negotiation program and STAT’s review of documents from the first round of negotiations.

Documentation 322

Documentation Diabetes Drug Pricing 322

STAT

OCTOBER 11, 2023

LAS VEGAS – Nick Jonas is a global superstar behind electrifying earworms like “Jealous,” “Chains,” and “Sucker,” one-third of the illustrious band The Jonas Brothers — and also a person who lives with type 1 diabetes.

Diabetes 354

Diabetes 354

STAT

NOVEMBER 14, 2023

In Stockton, California, almost 60% of the city’s 320,000 residents are prediabetic or living with diabetes. Shane Bailey, a 72-year-old longtime resident and U.S. Coast Guard veteran, is one of them.

Grocery Stores 337

Grocery Stores Diabetes 337

Express Pharma

MARCH 20, 2025

It is a treatment for obesity, overweight, and type 2 diabetes that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors. Mounjaro is also indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. per cent and 2.1

Diabetes 101

Diabetes Labelling Communication 101

Express Pharma

FEBRUARY 17, 2025

Nectar Life Care has launched a new range of anti-diabetic formulations, including Dapagliflozin under the brand name DAPNEC. India has a rising demand for diabetes management solutions, with the country often referred to as the Diabetes Capital of the World. The company reported INR 6.4

Diabetes 101

Diabetes 101

Med Ed 101

JANUARY 12, 2025

Treating patients with type II diabetes often requires an array of medications to control blood sugar and manage various comorbidities. In this article, we outline the top 10 drug […] The post Drug Interactions In Diabetes Care – Our Top 10 appeared first on Med Ed 101.

Diabetes 85

Diabetes 85

The Pharmacist

MAY 30, 2025

PCN pharmacy lead Gareth Malson offers his top ten tips for supporting people with diabetes to improve control of their condition at regular review The prevalence of diabetes is continuing to rise at an alarming rate. In 2023-24, the national diabetes register increased by around 21 people every hour, with 4.6m

Diabetes 93

Diabetes 93

STAT

APRIL 23, 2025

To date, Lilly and its rival, Novo Nordisk, have filed dozens of suits against numerous companies involved in compounding versions of semaglutide and tirzepatide, the obesity and diabetes drugs known as GLP-1s.

Compounding 341

Compounding Compounding Pharmacies Diabetes 341

Express Pharma

MARCH 31, 2025

HRV Global Life Sciences, a virtual integrated pharmaceutical company, delivers the first shipment of anti-diabetic medications to Mendoza, Argentina. The post HRV Global Life Sciences delivers Indian anti-diabetic drugs to Mendoza, Argentina appeared first on Express Pharma.

Diabetes 97

Diabetes Pharmaceutical Companies Pharmaceutical Companies 97

STAT

DECEMBER 26, 2023

The approach involves the “prescription” of healthy food to patients who are food insecure and suffering from uncontrolled type 2 diabetes (an HbA1c > 8). They could also participate in diabetes self-management training and cooking classes.

Diabetes 319

Diabetes 319

pharmaphorum

JULY 8, 2025

Boehringer has started a phase 2 trial of an oral therapy that could help people with diabetic macular oedema avoid regular injections into the eye

Diabetes 87

Diabetes 87

STAT

DECEMBER 19, 2024

In early October, the FDA pulled Eli Lilly’s tirzepatide — sold as Mounjaro for diabetes and Zepbound for obesity — off its drug shortage list after nearly two years.

Compounding 312

Compounding Compounding Pharmacies Diabetes 312

STAT

JUNE 5, 2025

People with diabetes who were taking GLP-1 drugs had a low but elevated risk of an age-related eye disease that can sometimes lead to blindness, a new observational study concludes, adding to a short list of concerns about eye health in people taking the powerful medications. The risk was 0.2% in people taking GLP-1s and 0.1%

Diabetes 295

Diabetes Drug Development 295

STAT

JUNE 30, 2025

Inflammaging is considered a hallmark of aging and has been believed to be a one-size-fits-all predictor of chronic age-related disease such as heart problems and diabetes.

Diabetes 267

Diabetes 267

STAT

AUGUST 22, 2024

Can Eli Lilly’s blockbuster obesity medicine lower the risk of diabetes? What does the hiring of a well-known industry dealmaker mean for the future of BioMarin Pharmaceuticals? And will Recursion Pharma, the AI drug developer, live up to all the hype? ” Read the rest…

Diabetes 260

Diabetes Drug Development 260

STAT

OCTOBER 31, 2024

These included diabetes, high blood pressure, fungal infections, asthma, anxiety, and rheumatoid arthritis. The state officials maintained that, as a result of the conspiracies, consumers paid more for the generic drugs than they would have otherwise if the U.S. marketplace had functioned competitively.

Diabetes 322

Diabetes Drug Pricing 322

STAT

JULY 9, 2025

About 1 in 3 young people who are 12 to 17 years old have prediabetes, new national data show, putting them at risk not just for type 2 diabetes but also for heart disease and stroke.   Experts said the data reflect a concerning rise in obesity among teens, but also noted that not all teens with prediabetes will progress to diabetes.

Diabetes 337

Diabetes 337

STAT

JANUARY 14, 2025

Eli Lilly’s expectations for sales in the fourth quarter of last year missed forecasts, driven by lower-than-expected sales of its diabetes and obesity drugs Mounjaro and Zepbound. This is another notable stumble for the company after its third-quarter earnings report disappointed. billion in revenue, less than the $13.9

Diabetes 276

Diabetes 276

STAT

DECEMBER 19, 2024

Although there is a caveat: This particular metric was based on a subset of just three drugs that were deemed to be fairly priced based on a cost-effectiveness assessment — the Mounjaro type 2 diabetes treatment, and the Wegovy and Qsymia obesity drugs. Continue to STAT+ to read the full story…

Department of Veterans Affairs 282

Department of Veterans Affairs Diabetes Drug Pricing 282

STAT

AUGUST 26, 2024

  Over the past 25 years, continuous glucose monitors have changed the shape of diabetes care.   Continue to STAT+ to read the full story…

Diabetes 357

Diabetes 357

STAT

SEPTEMBER 30, 2023

Next week, 50 medical experts from the Karolinska Institutet in Stockholm will meet to award the 2023 Nobel Prize for Physiology or Medicine. The vote takes place on Oct. 2, but betting-minded scientists are already beginning to make their picks for who might take home the gold.

Diabetes 363

Diabetes 363

World Pharma News

JUNE 26, 2025

These are some of the most promising effects of a new potential drug treatment for people with type 2 diabetes and obesity, according to a new study published in the journal Cell by researchers from Karolinska Institutet and Stockholm University.

Diabetes 73

Diabetes 73